​

HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCA Stock Forecast

HCA Healthcare (HCA) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $370.00, with a high of $370.00 and a low of $370.00. This represents a 8.64% increase from the last price of $340.58.

$250 $290 $330 $370 $410 $450 High: $370 Avg: $370 Low: $370 Last Closed Price: $340.58

HCA Stock Rating

HCA Healthcare stock's rating consensus is Buy, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 30 Buy (71.43%), 11 Hold (26.19%), 1 Sell (2.38%), and 0 Strong Sell (0.00%).

Buy
Total 42 1 11 30 Strong Sell Sell Hold Buy Strong Buy

HCA Price Target Upside V Benchmarks

TypeNameUpside
StockHCA Healthcare8.64%
SectorHealthcare Stocks 30.37%
IndustryMedical Care Facilities Stocks19.69%

Price Target Trends

1M3M12M
# Anlaysts--9
Avg Price Target--$414.00
Last Closing Price$340.58$340.58$340.58
Upside/Downside--21.56%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2521571-25
Mar, 2521571-25
Feb, 2521571-25
Jan, 2531571127
Dec, 2431551125
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 07, 2025Matthew GillmorKeyBanc$370.00$308.2120.05%8.64%
Oct 28, 2024Michael WiederhornOppenheimer$400.00$359.0711.40%17.45%
Oct 28, 2024Matthew GillmorKeyBanc$420.00$359.0716.97%23.32%
Oct 28, 2024Ann HynesMizuho Securities$425.00$359.1618.33%24.79%
Oct 10, 2024Matthew GillmorKeyBanc$475.00$387.2522.66%39.47%
Oct 01, 2024Pito ChickeringDeutsche Bank$441.00$406.018.62%29.48%
Aug 19, 2024David MacDonaldTruist Financial$430.00$373.7715.04%26.26%
Jun 28, 2024Pito ChickeringDeutsche Bank$375.00$335.0411.93%10.11%
Jun 06, 2024Brian TanquilutJefferies$390.00$336.8215.79%14.51%
Apr 29, 2024Ben HendrixRBC Capital$329.00$311.075.76%-3.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2025KeyBancOverweightOverweighthold
Oct 28, 2024OppenheimerOutperformOutperformhold
Oct 28, 2024KeyBancOverweightOverweighthold
Oct 16, 2024Cowen & Co.BuyBuyhold
Oct 10, 2024KeyBancOverweightinitialise
Oct 01, 2024Deutsche BankBuyBuyhold
Sep 03, 2024Morgan StanleyEqual-Weightinitialise
Aug 23, 2024RBC CapitalOutperformOutperformhold
Jul 30, 2024Wells FargoEqual-WeightEqual-Weighthold
Jul 25, 2024Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $7 $14 $21 $28 $35 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$11.10$21.51$19.44$19.24$0.08---
Avg Forecast$11.07$17.85$17.01$18.20$21.94$24.84$27.96$31.30
High Forecast$11.27$18.16$17.35$18.50$22.15$25.34$29.09$32.50
Low Forecast$10.95$17.65$16.82$18.04$21.82$24.06$27.03$30.19
Surprise %0.27%20.50%14.29%5.71%-99.64%---

Revenue Forecast

$50B $57B $64B $71B $78B $85B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$51.53B$58.75B$60.23B$64.97B$70.60B---
Avg Forecast$51.22B$59.02B$60.35B$64.15B$70.57B$74.57B$78.43B$82.55B
High Forecast$51.92B$59.82B$61.26B$64.42B$70.75B$75.20B$79.95B$82.68B
Low Forecast$50.80B$58.53B$59.82B$63.95B$70.43B$73.83B$77.42B$82.43B
Surprise %0.61%-0.46%-0.19%1.27%0.05%---

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$3.75B$6.96B$5.64B$5.24B$21.96M---
Avg Forecast$12.64B$5.84B$6.56B$5.24B$5.76B$6.47B$7.35B$8.21B
High Forecast$15.17B$7.01B$7.87B$6.29B$5.80B$6.63B$7.61B$8.51B
Low Forecast$10.11B$4.68B$5.25B$4.19B$5.71B$6.30B$7.08B$7.90B
Surprise %-70.30%19.01%-14.00%--99.62%---

HCA Forecast FAQ

Is HCA Healthcare stock a buy?

HCA Healthcare stock has a consensus rating of Buy, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 30 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that HCA Healthcare is a favorable investment for most analysts.

What is HCA Healthcare's price target?

HCA Healthcare's price target, set by 42 Wall Street analysts, averages $370 over the next 12 months. The price target range spans from $370 at the low end to $370 at the high end, suggesting a potential 8.64% change from the previous closing price of $340.58.

How does HCA Healthcare stock forecast compare to its benchmarks?

HCA Healthcare's stock forecast shows a 8.64% upside, underperforming the average forecast for the healthcare stocks sector (30.37%) and underperforming the medical care facilities stocks industry (19.69%).

What is the breakdown of analyst ratings for HCA Healthcare over the past three months?

  • April 2025: 8.00% Strong Buy, 60.00% Buy, 28.00% Hold, 4.00% Sell, 0% Strong Sell.
  • March 2025: 8.00% Strong Buy, 60.00% Buy, 28.00% Hold, 4.00% Sell, 0% Strong Sell.
  • February 2025: 8.00% Strong Buy, 60.00% Buy, 28.00% Hold, 4.00% Sell, 0% Strong Sell.

What is HCA Healthcare’s EPS forecast?

HCA Healthcare's average annual EPS forecast for its fiscal year ending in December 2025 is $24.84, marking a 30950.00% increase from the reported $0.08 in 2024. Estimates for the following years are $27.96 in 2026, and $31.3 in 2027.

What is HCA Healthcare’s revenue forecast?

HCA Healthcare's average annual revenue forecast for its fiscal year ending in December 2025 is $74.57B, reflecting a 5.61% increase from the reported $70.6B in 2024. The forecast for 2026 is $78.43B, and $82.55B for 2027.

What is HCA Healthcare’s net income forecast?

HCA Healthcare's net income forecast for the fiscal year ending in December 2025 stands at $6.47B, representing an 29342.21% increase from the reported $21.96M in 2024. Projections indicate $7.35B in 2026, and $8.21B in 2027.